1. Home
  2. NAII vs ADAP Comparison

NAII vs ADAP Comparison

Compare NAII & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • ADAP
  • Stock Information
  • Founded
  • NAII 1980
  • ADAP 2008
  • Country
  • NAII United States
  • ADAP United Kingdom
  • Employees
  • NAII N/A
  • ADAP N/A
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • ADAP Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAII Health Care
  • ADAP Health Care
  • Exchange
  • NAII Nasdaq
  • ADAP Nasdaq
  • Market Cap
  • NAII 21.2M
  • ADAP 21.3M
  • IPO Year
  • NAII 1987
  • ADAP 2015
  • Fundamental
  • Price
  • NAII $3.98
  • ADAP $0.06
  • Analyst Decision
  • NAII
  • ADAP Hold
  • Analyst Count
  • NAII 0
  • ADAP 6
  • Target Price
  • NAII N/A
  • ADAP $1.02
  • AVG Volume (30 Days)
  • NAII 2.8K
  • ADAP 89.0M
  • Earning Date
  • NAII 09-26-2025
  • ADAP 08-13-2025
  • Dividend Yield
  • NAII N/A
  • ADAP N/A
  • EPS Growth
  • NAII N/A
  • ADAP N/A
  • EPS
  • NAII N/A
  • ADAP N/A
  • Revenue
  • NAII $125,483,000.00
  • ADAP $65,084,999.00
  • Revenue This Year
  • NAII N/A
  • ADAP N/A
  • Revenue Next Year
  • NAII N/A
  • ADAP $52.35
  • P/E Ratio
  • NAII N/A
  • ADAP N/A
  • Revenue Growth
  • NAII 4.39
  • ADAP N/A
  • 52 Week Low
  • NAII $2.57
  • ADAP $0.05
  • 52 Week High
  • NAII $6.88
  • ADAP $1.33
  • Technical
  • Relative Strength Index (RSI)
  • NAII 69.88
  • ADAP 29.42
  • Support Level
  • NAII $3.62
  • ADAP $0.05
  • Resistance Level
  • NAII $4.00
  • ADAP $0.09
  • Average True Range (ATR)
  • NAII 0.08
  • ADAP 0.01
  • MACD
  • NAII 0.02
  • ADAP 0.00
  • Stochastic Oscillator
  • NAII 87.78
  • ADAP 7.21

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

Share on Social Networks: